Start: 12 Nov 2021, 13:00
End: 12 Nov 2021, 14:00
Chair: Mr James Glasbey, University of Birmingham, UK
Speaker: Dr Adewale Adisa, Obafemi Awolowo University, Nigeria
Speaker: Dr Lesley Booth MBE, Bowel Research UK, UK
Speaker: Dr Janet Martin, The University of Western Ontario, Canada
Speaker: Professor Richard Sullivan, King’s College London, UK
Surgery is the primary method of cancer control for most solid tumours. The SARS-CoV-2 pandemic has exposed the fragility of global cancer surgery systems with 1 in 7 patients not undergoing their planned cancer surgery during lockdowns. There have also been widespread delays to presentation, diagnosis, treatment initiation, multidisciplinary team decisions and resectional surgery, particularly in low-and-middle income countries. Sadly, this is likely to have long-term effects on recurrence and cancer survival.
In this session speakers will look back at the lessons learnt from cancer care during the pandemic and discuss how we can create a more resilient cancer surgery system for the future. They’ll also discuss how strengthening the system will have significant benefits for patients, communities and economies.